Terms: = Liver cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E
277 results:
1. A hierarchical fusion strategy of deep learning networks for detection and segmentation of hepatocellular carcinoma from computed tomography images.
Lee IC; Tsai YP; Lin YC; Chen TC; Yen CH; Chiu NC; Hwang HE; Liu CA; Huang JG; Lee RC; Chao Y; Ho SY; Huang YH
Cancer Imaging; 2024 Mar; 24(1):43. PubMed ID: 38532511
[TBL] [Abstract] [Full Text] [Related]
2. A novel disulfidptosis-related lncRNA signature for predicting prognosis and potential targeted therapy in hepatocellular carcinoma.
Zhang H; Wang J; Yang M
Medicine (Baltimore); 2024 Jan; 103(4):e36513. PubMed ID: 38277541
[TBL] [Abstract] [Full Text] [Related]
3. FGF19 and its analog Aldafermin cooperate with MYC to induce aggressive hepatocarcinogenesis.
Ursic-Bedoya J; Desandré G; Chavey C; Marie P; Polizzi A; Rivière B; Guillou H; Assenat E; Hibner U; Gregoire D
EMBO Mol Med; 2024 Feb; 16(2):238-250. PubMed ID: 38228803
[TBL] [Abstract] [Full Text] [Related]
4. Achaete-scute family bHLH transcription factor 2 activation promotes hepatoblastoma progression.
Kato Y; Fukazawa T; Tanimoto K; Kanawa M; Kojima M; Saeki I; Kurihara S; Touge R; Hirohashi N; Okada S; Hiyama E
Cancer Sci; 2024 Mar; 115(3):847-858. PubMed ID: 38183173
[TBL] [Abstract] [Full Text] [Related]
5. FAT4 loss initiates hepatocarcinogenesis through the switching of canonical to noncanonical WNT signaling pathways.
Huang FY; Wong DK; Mak LY; Cheung TT; Zhang SS; Chau HT; Hui RW; Seto WK; Yuen MF
Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38055646
[TBL] [Abstract] [Full Text] [Related]
6. Deep learning models for automatic tumor segmentation and total tumor volume assessment in patients with colorectal liver metastases.
Wesdorp NJ; Zeeuw JM; Postma SCJ; Roor J; van Waesberghe JHTM; van den Bergh JE; Nota IM; Moos S; Kemna R; Vadakkumpadan F; Ambrozic C; van Dieren S; van Amerongen MJ; Chapelle T; Engelbrecht MRW; Gerhards MF; Grunhagen D; van Gulik TM; Hermans JJ; de Jong KP; Klaase JM; Liem MSL; van Lienden KP; Molenaar IQ; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Marquering HA; Stoker J; Swijnenburg RJ; Punt CJA; Huiskens J; Kazemier G
Eur Radiol Exp; 2023 Dec; 7(1):75. PubMed ID: 38038829
[TBL] [Abstract] [Full Text] [Related]
7. Is the anterior approach recommended for liver resection of hepatocellular carcinoma? A systematic review and meta-analysis.
Ishii T; Iwaki K; Nakakura A; Uchida Y; Ito T; Hatano E
J Hepatobiliary Pancreat Sci; 2024 Mar; 31(3):133-142. PubMed ID: 37984829
[TBL] [Abstract] [Full Text] [Related]
8. The Molecular, Immunologic, and Clinicodemographic Landscape of MYC-Amplified Advanced Prostate cancer.
Jin WH; Zhang L; Graf R; Raskina K; Tukachinsky H; Huang RSP; McGregor K; Alshalalfa M; Hougen HY; Khan A; Punnen S; Schrock AB; Venstrom J; Mahal BA
Clin Genitourin Cancer; 2024 Feb; 22(1):e163-e169.e1. PubMed ID: 37978032
[TBL] [Abstract] [Full Text] [Related]
9. CENPA functions as a transcriptional regulator to promote hepatocellular carcinoma progression via cooperating with YY1.
Liao J; Chen Z; Chang R; Yuan T; Li G; Zhu C; Wen J; Wei Y; Huang Z; Ding Z; Chu L; Liang J; Zhang B
Int J Biol Sci; 2023; 19(16):5218-5232. PubMed ID: 37928273
[TBL] [Abstract] [Full Text] [Related]
10. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract] [Full Text] [Related]
11. A multicenter validation study for determining the condition of nonanatomical or minor anatomical hepatectomies satisfying technical difficulty of current high-level hepatectomy certificated by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Matsuki R; Sakamoto Y; Yoshida M; Ogiso S; Soyama A; Seki Y; Tokumitsu Y; Eguchi S; Hasegawa K; Nagano H; Kokudo N; Hatano E
J Hepatobiliary Pancreat Sci; 2023 Nov; 30(11):1218-1226. PubMed ID: 37798934
[TBL] [Abstract] [Full Text] [Related]
12. Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice.
Kong Q; Zhu H; Gong W; Deng X; Liu B; Dong J
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117183. PubMed ID: 37739106
[TBL] [Abstract] [Full Text] [Related]
13. Multi-omics analyses of glucose metabolic reprogramming in colorectal cancer.
Huang M; Wu Y; Cheng L; Fu L; Yan H; Ru H; Mo X; Yan L; Su Z
Front Immunol; 2023; 14():1179699. PubMed ID: 37475862
[TBL] [Abstract] [Full Text] [Related]
14. Vasorin promotes proliferation and migration via STAT3 signaling and acts as a promising therapeutic target of hepatocellular carcinoma.
Wan F; Li H; Huang S; Sun J; Li J; Li Y; Yang L; He M
Cell Signal; 2023 Oct; 110():110809. PubMed ID: 37454705
[TBL] [Abstract] [Full Text] [Related]
15. Yiqi Huayu Jiedu Decoction inhibits liver metastasis of colorectal cancer via enhancing natural killer cells function.
Zhou JY; Wu C; Shen Z; Liu S; Zou X; Qian J; Wu Z; Huan X; Mu BX; Ye N; Ning Y; Wang Y; Chen M; Zhuang Y
J Ethnopharmacol; 2024 Jan; 318(Pt A):116915. PubMed ID: 37451487
[TBL] [Abstract] [Full Text] [Related]
16. Long Non-coding RNA LINC00342 Promotes the Proliferation, Invasion, and Migration of Primary Hepatocellular Carcinoma Cells by Regulating the Expression of miRNA-19a-3p, miRNA-545-5p, and miRNA-203a-3p.
Yao ZX; Tu JH; Liu YL; Xue XF; Qin L
Biochem Genet; 2024 Apr; 62(2):675-697. PubMed ID: 37395850
[TBL] [Abstract] [Full Text] [Related]
17. Comprehensive chemical profiling of two Dendrobium species and identification of anti-hepatoma active constituents from Dendrobium chrysotoxum by network pharmacology.
Jie X; Feng Y; Jiahao F; Ganggui L; Jiani Y; Zhongyu X; Yuan Y; Tinggang Z; Xiaodan Z; Zongsuo L
BMC Complement Med Ther; 2023 Jul; 23(1):217. PubMed ID: 37393306
[TBL] [Abstract] [Full Text] [Related]
18. Machine learning for malignant versus benign focal liver lesions on US and CEUS: a meta-analysis.
Campello CA; Castanha EB; Vilardo M; Staziaki PV; Francisco MZ; Mohajer B; Watte G; Moraes FY; Hochhegger B; Altmayer S
Abdom Radiol (NY); 2023 Oct; 48(10):3114-3126. PubMed ID: 37365266
[TBL] [Abstract] [Full Text] [Related]
19. CSNK2A2 promotes hepatocellular carcinoma progression through activation of NF-κB pathway.
Yang S; Peng LR; Yu AQ; Li J
Ann Hepatol; 2023; 28(5):101118. PubMed ID: 37268061
[TBL] [Abstract] [Full Text] [Related]
20. Gene variations related to the hepatocellular carcinoma: Results from a field synopsis and Bayesian revaluation.
Penha Mesquita A; Victor Oliveira Monteiro A; Luiz Araújo Bentes Leal A; Dos Santos Pessoa L; de Siqueira Amorim Júnior J; Rogério Souza Monteiro J; Andrade de Sousa A; Fernando Pereira Vasconcelos D; Carolina Alves de Oliveira A; Leão Pereira A; Rodolfo Pereira da Silva F
Gene; 2023 Jun; 869():147392. PubMed ID: 36966980
[TBL] [Abstract] [Full Text] [Related]
[Next]
